Fengtian Li

529 citations
17 papers · 280 indexed · h-index 8
Topics
Ubiquitin and proteasome pathways (5 papers)Cancer-related Molecular Pathways (3 papers)Photorefractive and Nonlinear Optics (2 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Fengtian Li

16 papers receiving 279 citations

Peers

Fengtian Li
Comparison fields: 5 of 74
  • Molecular Biology 179
  • Oncology 85
  • Cancer Research 64
  • Immunology 42
  • Pulmonary and Respiratory Medicine 30
Replace Guifang Gan with:
Guifang Gan China
Weiqian Li China
Elisa M. Noll Germany
Shakchhi Joshi United States
Timothy Chan United States
Ethan Ahler United States
Benjamin A. Turner United States
Minyu Chen China
Stijn Vereecke Belgium
Maarten Swart United Kingdom
Fengtian Li relative to Guifang Gan China Guifang Gan's profile →
Citations per field
00.5×3.4×
Guifang Gan · 1×
Citations per year

Countries citing papers authored by Fengtian Li

Since Specialization
Citations

This map shows the geographic impact of Fengtian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengtian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengtian Li more than expected).

Fields of papers citing papers by Fengtian Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengtian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengtian Li. The network helps show where Fengtian Li may publish in the future.

Co-authorship network of co-authors of Fengtian Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fengtian Li. A scholar is included among the top collaborators of Fengtian Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengtian Li. Fengtian Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 10
2 0
3 2
4 2
5 13
6 5
7 14
8 120
9 12
10 8
11 55
12 5
13 24
14 2
15
A new method for improving beam quality of LINAC
1
16 1
17 6

About Fengtian Li

Fengtian Li is a scholar working on Biological Psychiatry, Geology and Molecular Biology, having authored 17 papers that have together received 280 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (3 papers) and Photorefractive and Nonlinear Optics (2 papers). The work is most often cited by research in Biological Psychiatry (20 citations), Cancer Research (64 citations) and Oncology (85 citations). Fengtian Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Zhi‐Xiong Jim Xiao, Wenting Liao, Yong Yi, Mengmeng Niu, Chao Zhang, Libing Song, Yunting Jian, Yue Li, Chuyong Lin and Huilin Huang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026